Bayesian Capital Management’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,100
Closed -$66.2K 113
2025
Q3
$66.2K Buy
+11,100
New +$54.2K 0.01% 496
2025
Q2
Sell
-41,501
Closed -$182K 511
2025
Q1
$182K Buy
+41,501
New +$196K 0.03% 503
2021
Q4
Sell
-15,880
Closed -$1.1M 365
2021
Q3
$1.1M Buy
15,880
+13,780
+656% +$979K 0.32% 81
2021
Q2
$190K Sell
2,100
-910
-30% -$78.8K 0.05% 370
2021
Q1
$280K Sell
3,010
-6,490
-68% -$725K 0.06% 362
2020
Q4
$789K Buy
9,500
+6,834
+256% +$498K 0.21% 143
2020
Q3
$124K Buy
+2,666
New +$253K 0.03% 469

Other funds holding ACB

Bayesian Capital Management's ACB Position: Q4 2025 in Review

Bayesian Capital Management sold out of Aurora Cannabis (ACB) in Q4 2025, closing a stake of 11,100 shares — an estimated $66.2K sold.

Bayesian Capital Management first reported a position in ACB in Q3 2020 and held it in 7 quarters. The position peaked at $1.1M in Q3 2021. 171 funds tracked by Wall St. Rank hold ACB as of Q4 2025.

  • Bayesian Capital Management reported no remaining Aurora Cannabis position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 11,100 Aurora Cannabis shares in Q4 2025, an estimated $66.2K.
  • Bayesian Capital Management first reported a position in Aurora Cannabis in Q3 2020 and held it in 7 quarters.
  • Bayesian Capital Management's Aurora Cannabis position peaked at $1.1M in Q3 2021.
  • 171 funds tracked by Wall St. Rank held Aurora Cannabis as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.